Testing solriamfetol for children with ADHD
Part of Mental health clinical trials.
This trial tests whether a medication called solriamfetol can safely help children with ADHD. If your child is between 6 and 12 years old and has ADHD, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 6 to under 12 years old.
- Your child must have a confirmed ADHD diagnosis (using standard criteria).
- You and your child must agree to join the study and sign consent forms.
- Your child must not have any medical reason that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, solriamfetol, to see if it helps teenagers with ADHD. The medicine is taken as a tablet and may improve focus and reduce symptoms.
This study checks the long-term safety of the drug solriamfetol for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents who have already completed an earlier study of this medication.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This trial tests a non-invasive brain stimulation treatment (called rTMS) to see if it can help reduce ADHD symptoms in children and adolescents. It may offer an additional treatment option beyond medication.
This study tests a medication called Solriamfetol (Sunosi) to see if it helps people with shift work disorder stay awake and alert during their shifts. It is a Phase 3 trial, which means it is being studied in a larger group to confirm how well it works and check for side effects.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.